Novel raag10 cell surface target and a family of antibodies recognizing that target
CA 2490399 C · Owner: Li, Rong-Hao · Inventors: Roberts, Penelope E.; Li, Rong-Hao; Pan, Zhuangyu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10 methods of diagnosing and , treating various human cancers and diseases that express RAAG10.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 19, 2003 and granted October 6, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 19, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 19, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.